Global Gene Therapy Market Size, Status and Forecast 2019-2025

Published on: Feb 2019 | From USD 3900 | Number Of Pages: 94 | Life Sciences

Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.
Gene therapy is a method that involves introducing genetic material into a person’s cells to fight or prevent diseases. In recent decades of years, researchers are paying more and more attention on it. Until today, it is still in infancy. There are many bio-technology companies entered into this market and carry on related research and development.

These research companies are including Bluebird Bio, Sangamom, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio, Celladon, Vical and Advantagene. Among them, the top 5 research companies occupied more than 85% market.

Generally, the research fees of companies are come from their collaboration partners. For example, Bayer Healthcare is the partner of Dimension Therapeutics. General, some products of these companies are in the period 3 of their pipeline.

In general, cancer diseases are still the largest application with market share over 65% in 2015. In addition, there are some companies are focus on rare diseases.

In 2018, the global Gene Therapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Gene Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gene Therapy development in United States, Europe and China.

The key players covered in this study
Bluebird Bio
Sangamo
Spark Therapeutics
Dimension Therapeutics
Avalanche Bio
Celladon
Vical Inc.
Advantagene

Market segment by Type, the product can be split into
Ex vivo
In Vivo

Market segment by Application, split into
Cancer
Monogenic
Infectious disease
Cardiovascular disease
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Gene Therapy status, future forecast, growth opportunity, key market and key players.
To present the Gene Therapy development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Gene Therapy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Gene Therapy Market Size Growth Rate by Type (2014-2025)
1.4.2 Ex vivo
1.4.3 In Vivo
1.5 Market by Application
1.5.1 Global Gene Therapy Market Share by Application (2014-2025)
1.5.2 Cancer
1.5.3 Monogenic
1.5.4 Infectious disease
1.5.5 Cardiovascular disease
1.5.6 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Gene Therapy Market Size
2.2 Gene Therapy Growth Trends by Regions
2.2.1 Gene Therapy Market Size by Regions (2014-2025)
2.2.2 Gene Therapy Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Gene Therapy Market Size by Manufacturers
3.1.1 Global Gene Therapy Revenue by Manufacturers (2014-2019)
3.1.2 Global Gene Therapy Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.2 Gene Therapy Key Players Head office and Area Served
3.3 Key Players Gene Therapy Product/Solution/Service
3.4 Date of Enter into Gene Therapy Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Gene Therapy Market Size by Type (2014-2019)
4.2 Global Gene Therapy Market Size by Application (2014-2019)

5 United States
5.1 United States Gene Therapy Market Size (2014-2019)
5.2 Gene Therapy Key Players in United States
5.3 United States Gene Therapy Market Size by Type
5.4 United States Gene Therapy Market Size by Application

6 Europe
6.1 Europe Gene Therapy Market Size (2014-2019)
6.2 Gene Therapy Key Players in Europe
6.3 Europe Gene Therapy Market Size by Type
6.4 Europe Gene Therapy Market Size by Application

7 China
7.1 China Gene Therapy Market Size (2014-2019)
7.2 Gene Therapy Key Players in China
7.3 China Gene Therapy Market Size by Type
7.4 China Gene Therapy Market Size by Application

8 Japan
8.1 Japan Gene Therapy Market Size (2014-2019)
8.2 Gene Therapy Key Players in Japan
8.3 Japan Gene Therapy Market Size by Type
8.4 Japan Gene Therapy Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Gene Therapy Market Size (2014-2019)
9.2 Gene Therapy Key Players in Southeast Asia
9.3 Southeast Asia Gene Therapy Market Size by Type
9.4 Southeast Asia Gene Therapy Market Size by Application

10 India
10.1 India Gene Therapy Market Size (2014-2019)
10.2 Gene Therapy Key Players in India
10.3 India Gene Therapy Market Size by Type
10.4 India Gene Therapy Market Size by Application

11 Central & South America
11.1 Central & South America Gene Therapy Market Size (2014-2019)
11.2 Gene Therapy Key Players in Central & South America
11.3 Central & South America Gene Therapy Market Size by Type
11.4 Central & South America Gene Therapy Market Size by Application

12 International Players Profiles
12.1 Bluebird Bio
12.1.1 Bluebird Bio Company Details
12.1.2 Company Description and Business Overview
12.1.3 Gene Therapy Introduction
12.1.4 Bluebird Bio Revenue in Gene Therapy Business (2014-2019)
12.1.5 Bluebird Bio Recent Development
12.2 Sangamo
12.2.1 Sangamo Company Details
12.2.2 Company Description and Business Overview
12.2.3 Gene Therapy Introduction
12.2.4 Sangamo Revenue in Gene Therapy Business (2014-2019)
12.2.5 Sangamo Recent Development
12.3 Spark Therapeutics
12.3.1 Spark Therapeutics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Gene Therapy Introduction
12.3.4 Spark Therapeutics Revenue in Gene Therapy Business (2014-2019)
12.3.5 Spark Therapeutics Recent Development
12.4 Dimension Therapeutics
12.4.1 Dimension Therapeutics Company Details
12.4.2 Company Description and Business Overview
12.4.3 Gene Therapy Introduction
12.4.4 Dimension Therapeutics Revenue in Gene Therapy Business (2014-2019)
12.4.5 Dimension Therapeutics Recent Development
12.5 Avalanche Bio
12.5.1 Avalanche Bio Company Details
12.5.2 Company Description and Business Overview
12.5.3 Gene Therapy Introduction
12.5.4 Avalanche Bio Revenue in Gene Therapy Business (2014-2019)
12.5.5 Avalanche Bio Recent Development
12.6 Celladon
12.6.1 Celladon Company Details
12.6.2 Company Description and Business Overview
12.6.3 Gene Therapy Introduction
12.6.4 Celladon Revenue in Gene Therapy Business (2014-2019)
12.6.5 Celladon Recent Development
12.7 Vical Inc.
12.7.1 Vical Inc. Company Details
12.7.2 Company Description and Business Overview
12.7.3 Gene Therapy Introduction
12.7.4 Vical Inc. Revenue in Gene Therapy Business (2014-2019)
12.7.5 Vical Inc. Recent Development
12.8 Advantagene
12.8.1 Advantagene Company Details
12.8.2 Company Description and Business Overview
12.8.3 Gene Therapy Introduction
12.8.4 Advantagene Revenue in Gene Therapy Business (2014-2019)
12.8.5 Advantagene Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures

Table Gene Therapy Key Market Segments
Table Key Players Gene Therapy Covered
Table Global Gene Therapy Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Gene Therapy Market Size Market Share by Type 2014-2025
Figure Ex vivo Figures
Table Key Players of Ex vivo
Figure In Vivo Figures
Table Key Players of In Vivo
Table Global Gene Therapy Market Size Growth by Application 2014-2025 (Million US$)
Figure Cancer Case Studies
Figure Monogenic Case Studies
Figure Infectious disease Case Studies
Figure Cardiovascular disease Case Studies
Figure Other Case Studies
Figure Gene Therapy Report Years Considered
Table Global Gene Therapy Market Size 2014-2025 (Million US$)
Figure Global Gene Therapy Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Gene Therapy Market Size by Regions 2014-2025 (Million US$)
Table Global Gene Therapy Market Size by Regions 2014-2019 (Million US$)
Table Global Gene Therapy Market Share by Regions 2014-2019
Figure Global Gene Therapy Market Share by Regions 2014-2019
Figure Global Gene Therapy Market Share by Regions 2019
Table Market Top Trends
Table Global Gene Therapy Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Gene Therapy Market Share by Manufacturers (2014-2019)
Figure Global Gene Therapy Market Share by Manufacturers in 2018
Table Global Gene Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Gene Therapy Product/Solution/Service
Table Date of Enter into Gene Therapy Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Gene Therapy Market Size by Type (2014-2019) (Million US$)
Table Global Gene Therapy Market Size Share by Type (2014-2019)
Figure Global Gene Therapy Market Size Market Share by Type (2014-2019)
Table Global Gene Therapy Market Size by Application (2014-2019) (Million US$)
Table Global Gene Therapy Market Size Share by Application (2014-2019)
Figure Global Gene Therapy Market Size Market Share by Application (2014-2019)
Figure Global Gene Therapy Revenue Market Share by Application in 2018
Figure United States Gene Therapy Market Size 2014-2019 (Million US$)
Table United States Key Players Gene Therapy Revenue (2018-2019) (Million US$)
Table United States Key Players Gene Therapy Market Share (2018-2019)
Table United States Gene Therapy Market Size by Type (2014-2019) (Million US$)
Table United States Gene Therapy Market Share by Type (2014-2019)
Table United States Gene Therapy Market Size by Application (2014-2019) (Million US$)
Table United States Gene Therapy Market Share by Application (2014-2019)
Figure Europe Gene Therapy Market Size 2014-2019 (Million US$)
Table Europe Key Players Gene Therapy Revenue (2018-2019) (Million US$)
Table Europe Key Players Gene Therapy Market Share (2018-2019)
Table Europe Gene Therapy Market Size by Type (2014-2019) (Million US$)
Table Europe Gene Therapy Market Share by Type (2014-2019)
Table Europe Gene Therapy Market Size by Application (2014-2019) (Million US$)
Table Europe Gene Therapy Market Share by Application (2014-2019)
Figure China Gene Therapy Market Size 2014-2019 (Million US$)
Table China Key Players Gene Therapy Revenue (2018-2019) (Million US$)
Table China Key Players Gene Therapy Market Share (2018-2019)
Table China Gene Therapy Market Size by Type (2014-20189) (Million US$)
Table China Gene Therapy Market Share by Type (2014-2019)
Table China Gene Therapy Market Size by Application (2014-2019) (Million US$)
Table China Gene Therapy Market Share by Application (2014-2019)
Figure Japan Gene Therapy Market Size 2014-2019 (Million US$)
Table Japan Key Players Gene Therapy Revenue (2018-2019) (Million US$)
Table Japan Key Players Gene Therapy Market Share (2018-2019)
Table Japan Gene Therapy Market Size by Type (2014-2019) (Million US$)
Table Japan Gene Therapy Market Share by Type (2014-2019)
Table Japan Gene Therapy Market Size by Application (2014-2019) (Million US$)
Table Japan Gene Therapy Market Share by Application (2014-2019)
Figure Southeast Asia Gene Therapy Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Gene Therapy Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Gene Therapy Market Share (2018-2019)
Table Southeast Asia Gene Therapy Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Gene Therapy Market Share by Type (2014-2019)
Table Southeast Asia Gene Therapy Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Gene Therapy Market Share by Application (2014-2019)
Figure India Gene Therapy Market Size 2014-2019 (Million US$)
Table India Key Players Gene Therapy Revenue (2018-2019) (Million US$)
Table India Key Players Gene Therapy Market Share (2018-2019)
Table India Gene Therapy Market Size by Type (2014-2019) (Million US$)
Table India Gene Therapy Market Share by Type (2014-2019)
Table India Gene Therapy Market Size by Application (2014-2019) (Million US$)
Table India Gene Therapy Market Share by Application (2014-2019)
Figure Central & South America Gene Therapy Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Gene Therapy Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Gene Therapy Market Share (2018-2019)
Table Central & South America Gene Therapy Market Size by Type (2014-2019) (Million US$)
Table Central & South America Gene Therapy Market Share by Type (2014-2019)
Table Central & South America Gene Therapy Market Size by Application (2014-2019) (Million US$)
Table Central & South America Gene Therapy Market Share by Application (2014-2019)
Table Bluebird Bio Company Details
Table Bluebird Bio Revenue in Gene Therapy Business (2014-2019) (Million US$)
Figure Bluebird Bio Revenue Growth Rate in Gene Therapy Business (2014-2019)
Table Bluebird Bio Recent Development
Table Sangamo Company Details
Table Sangamo Revenue in Gene Therapy Business (2014-2019)(Million US$)
Figure Sangamo Revenue Growth Rate in Gene Therapy Business (2014-2019)
Table Sangamo Recent Development
Table Spark Therapeutics Company Details
Table Spark Therapeutics Revenue in Gene Therapy Business (2014-2019)(Million US$)
Figure Spark Therapeutics Revenue Growth Rate in Gene Therapy Business (2014-2019)
Table Spark Therapeutics Recent Development
Table Dimension Therapeutics Company Details
Table Dimension Therapeutics Revenue in Gene Therapy Business (2014-2019)(Million US$)
Figure Dimension Therapeutics Revenue Growth Rate in Gene Therapy Business (2014-2019)
Table Dimension Therapeutics Recent Development
Table Avalanche Bio Company Details
Table Avalanche Bio Revenue in Gene Therapy Business (2014-2019)(Million US$)
Figure Avalanche Bio Revenue Growth Rate in Gene Therapy Business (2014-2019)
Table Avalanche Bio Recent Development
Table Celladon Company Details
Table Celladon Revenue in Gene Therapy Business (2014-2019)(Million US$)
Figure Celladon Revenue Growth Rate in Gene Therapy Business (2014-2019)
Table Celladon Recent Development
Table Vical Inc. Company Details
Table Vical Inc. Revenue in Gene Therapy Business (2014-2019)(Million US$)
Figure Vical Inc. Revenue Growth Rate in Gene Therapy Business (2014-2019)
Table Vical Inc. Recent Development
Table Advantagene Company Details
Table Advantagene Revenue in Gene Therapy Business (2014-2019)(Million US$)
Figure Advantagene Revenue Growth Rate in Gene Therapy Business (2014-2019)
Table Advantagene Recent Development
Table Global Gene Therapy Market Size by Regions (Million US$) 2019-2025
Figure Global Gene Therapy Market Size Share by Regions (2019-2025)
Figure Global Gene Therapy Market Size Share by Regions in 2025
Figure United States Gene Therapy Market Size Forecast (2019-2025)(Million USD)
Figure Europe Gene Therapy Market Size Forecast (2019-2025)(Million USD)
Figure China Gene Therapy Market Size Forecast (2019-2025)(Million USD)
Figure Japan Gene Therapy Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Gene Therapy Market Size Forecast (2019-2025)(Million USD)
Figure India Gene Therapy Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Gene Therapy Market Size Forecast (2019-2025)(Million USD)
Table Global Gene Therapy Market Size by Product (2019-2025) (Million US$)
Figure Global Gene Therapy Market Size by Product (2019-2025)
Figure Global Gene Therapy Market Size by Product in 2025
Table Global Gene Therapy Market Size by Application (2019-2025) (Million US$)
Figure Global Gene Therapy Market Size by Application (2019-2025)
Figure Global Gene Therapy Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
SECONDARY RESEARCH

Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH

Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING

The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION

The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION

After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.